Fasciola hepatica in a German Traveler Returning From Thailand

Standard

Fasciola hepatica in a German Traveler Returning From Thailand. / Schmiedel, Stefan; Salzer, Helmut.

In: J TRAVEL MED, Vol. 22, No. 4, 08.2015, p. 285–286.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{5915487436e64faa8555e2e1ec534e84,
title = "Fasciola hepatica in a German Traveler Returning From Thailand",
abstract = "A 46-year-old man presented with nonspecific clinical signs including abdominal pain, diarrhea, fatigue, and nausea after returning from a trip to the northeast of Thailand 5 months ago. Laboratory diagnostics revealed a hypereosinophilia of 45% and slightly elevated cholestatic liver enzymes with an alkaline phosphatase of 163 U/L (40–129 U/L) and a gamma-glutamyl transferase of 109 U/L (−65 U/L); besides serological confirmation, repeated stool samples showed the eggs of Fasciola hepatica (miracidia of F. hepatica measuring 136 × 74 µm). The abdominal T1-weighted axial magnetic resonance imaging (MRI) showed multiple tubular, hypointense parenchymal lesions in liver segments II, IVa, and VII representing pyogenic microabscesses consistent with F. hepatica; mild dilatations of the intrahepatic bile duct with a mild reactive/inflammatory reaction were identified, but with no significant cholestasis (Figures 1 and 2). The patient was started on oral therapy with triclabendazol (10 mg/kg) single dose. Infections with the trematode F. hepatica are an extremely rare phenomenon among travelers, despite the high disease burden among local populations in endemic areas; therefore, F. hepatica infections should be kept in mind when dealing with patients with a relevant travel history suffering from nonspecific signs and hypereosinophilia.",
author = "Stefan Schmiedel and Helmut Salzer",
year = "2015",
month = aug,
language = "English",
volume = " 22",
pages = "285–286",
journal = "J TRAVEL MED",
issn = "1195-1982",
publisher = "Wiley-Blackwell",
number = " 4",

}

RIS

TY - JOUR

T1 - Fasciola hepatica in a German Traveler Returning From Thailand

AU - Schmiedel, Stefan

AU - Salzer, Helmut

PY - 2015/8

Y1 - 2015/8

N2 - A 46-year-old man presented with nonspecific clinical signs including abdominal pain, diarrhea, fatigue, and nausea after returning from a trip to the northeast of Thailand 5 months ago. Laboratory diagnostics revealed a hypereosinophilia of 45% and slightly elevated cholestatic liver enzymes with an alkaline phosphatase of 163 U/L (40–129 U/L) and a gamma-glutamyl transferase of 109 U/L (−65 U/L); besides serological confirmation, repeated stool samples showed the eggs of Fasciola hepatica (miracidia of F. hepatica measuring 136 × 74 µm). The abdominal T1-weighted axial magnetic resonance imaging (MRI) showed multiple tubular, hypointense parenchymal lesions in liver segments II, IVa, and VII representing pyogenic microabscesses consistent with F. hepatica; mild dilatations of the intrahepatic bile duct with a mild reactive/inflammatory reaction were identified, but with no significant cholestasis (Figures 1 and 2). The patient was started on oral therapy with triclabendazol (10 mg/kg) single dose. Infections with the trematode F. hepatica are an extremely rare phenomenon among travelers, despite the high disease burden among local populations in endemic areas; therefore, F. hepatica infections should be kept in mind when dealing with patients with a relevant travel history suffering from nonspecific signs and hypereosinophilia.

AB - A 46-year-old man presented with nonspecific clinical signs including abdominal pain, diarrhea, fatigue, and nausea after returning from a trip to the northeast of Thailand 5 months ago. Laboratory diagnostics revealed a hypereosinophilia of 45% and slightly elevated cholestatic liver enzymes with an alkaline phosphatase of 163 U/L (40–129 U/L) and a gamma-glutamyl transferase of 109 U/L (−65 U/L); besides serological confirmation, repeated stool samples showed the eggs of Fasciola hepatica (miracidia of F. hepatica measuring 136 × 74 µm). The abdominal T1-weighted axial magnetic resonance imaging (MRI) showed multiple tubular, hypointense parenchymal lesions in liver segments II, IVa, and VII representing pyogenic microabscesses consistent with F. hepatica; mild dilatations of the intrahepatic bile duct with a mild reactive/inflammatory reaction were identified, but with no significant cholestasis (Figures 1 and 2). The patient was started on oral therapy with triclabendazol (10 mg/kg) single dose. Infections with the trematode F. hepatica are an extremely rare phenomenon among travelers, despite the high disease burden among local populations in endemic areas; therefore, F. hepatica infections should be kept in mind when dealing with patients with a relevant travel history suffering from nonspecific signs and hypereosinophilia.

M3 - SCORING: Journal article

VL - 22

SP - 285

EP - 286

JO - J TRAVEL MED

JF - J TRAVEL MED

SN - 1195-1982

IS - 4

ER -